Jeff Renwick, CEO & Director, Canntab Therapeutics Ltd.

Jeff Renwick, serves as the Chief Executive Officer and Director of Canntab Therapeutics Limited, a cannabis oral dosage formulation company, researches and develops advanced pharmaceutical grade formulations of cannabinoids in Canada.

With extensive experience in drug formulation and business development, Jeff also served as the President and Chief Executive Officer of Orbus Pharma Inc. He is a pharmaceutical executive with over 15 years of international industry experience covering manufacturing, purchasing, distribution, marketing and product development, as well as mergers and acquisitions in North America, Europe, Caribbean and South America.